The long-term objectives of this application are to understand at a molecular and cellular level the roles of erythroid membrane proteins, hematopoietic growth factor receptors, signal transduction protein, and transcription factors during erythropoiesis. Dr. Lodish will focus on the b common chain of the IL-3/GM-CSF/IL-5 receptor and the erythropoietin receptor, respectively. Their role in erythroid differentiation will be investigated through the use of chimeric receptor constructs, receptor cytoplasmic domain fusion proteins to identify transduction proteins and their binding sites, dominant negative/positive mutants of signalling proteins such as stat and MAP kinases, assessing their function both in vitro in cell lines and fetal liver and embryonal stem (ES) cells, and in vivo in transgenic and targeted gene replacement of knock-in mice. Dr. Zon will compliment these studies by identifying novel kinases of different MAP kinase cascades and assessing their role during the development of erythroid cells. This project will also provide a bridge to Dr. Orkin's project by providing the means to define the role of three different MAP kinase cascades in transducing signals from the IL-3 and erythropoietin receptors, and in activating erythroid specific transcription factors. Dr. Orkin's project will focus on the structure-function studies of the role of GATA-1 in erythroid cells and identification of GATA factor dependent target genes critical for terminal erythroid development. Dr. Lux will study the function of ankyrin in erythroid cells through the use of targeted gene disruption and gene replacement strategies in ES cells. By these means we hope to understand more fully the process of erythropoiesis and obtain molecular insights into disorders of failure, abnormal production, or increased proliferation of erythroid cells.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital Boston
United States
Zip Code
Huang, Nai-Jia; Lin, Ying-Cing; Lin, Chung-Yueh et al. (2018) Enhanced phosphocholine metabolism is essential for terminal erythropoiesis. Blood 131:2955-2966
Schoonenberg, Vivien A C; Cole, Mitchel A; Yao, Qiuming et al. (2018) CRISPRO: identification of functional protein coding sequences based on genome editing dense mutagenesis. Genome Biol 19:169
Lessard, Samuel; Beaudoin, Mélissa; Orkin, Stuart H et al. (2018) 14q32 and let-7 microRNAs regulate transcriptional networks in fetal and adult human erythroblasts. Hum Mol Genet 27:1411-1420
Esrick, Erica B; Bauer, Daniel E (2018) Genetic therapies for sickle cell disease. Semin Hematol 55:76-86
Yien, Yvette Y; Shi, Jiahai; Chen, Caiyong et al. (2018) FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity. J Biol Chem 293:19797-19811
Wattrus, Samuel J; Zon, Leonard I (2018) Stem cell safe harbor: the hematopoietic stem cell niche in zebrafish. Blood Adv 2:3063-3069
Uenishi, Gene I; Jung, Ho Sun; Kumar, Akhilesh et al. (2018) NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nat Commun 9:1828
Yu, Shan-He; Zhu, Kang-Yong; Zhang, Fan et al. (2018) The histone demethylase Jmjd3 regulates zebrafish myeloid development by promoting spi1 expression. Biochim Biophys Acta Gene Regul Mech 1861:106-116
Parada-Kusz, Margarita; Penaranda, Cristina; Hagedorn, Elliott J et al. (2018) Generation of mouse-zebrafish hematopoietic tissue chimeric embryos for hematopoiesis and host-pathogen interaction studies. Dis Model Mech 11:
Rost, Megan S; Shestopalov, Ilya; Liu, Yang et al. (2018) Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish. Blood Adv 2:3418-3427

Showing the most recent 10 out of 215 publications